Spider9 and Easypower Awarded 2 MWh Energy Storage Project

Northville, Mich (PRWEB) August 07, 2013

Spider9, a clean energy solutions company, and European energy systems provider Easypower announced today that they will partner to deliver a 2 MWh grid-tied energy storage system in Europe. The 2 MWh energy storage system is an integrated part of a larger multi-megawatt solar installation that will be installed by Easypower early next year and will provide load shifting, firming and power factor correction capabilities.

Easypower, who was awarded the project, targeted energy storage as the key differentiator to the project’s success and goals of providing higher system reliability and energy management flexibility. “We wanted to make sure that we were partnered with the technology leader in the market. Spider9’s OSE provides not only increased efficiency and lower operating costs, but also a platform that can adapt to new technology. This is of great importance when making a long-term technology investment,” said Nikos Savouris, Vice President of Easypower, S.A.

“Spider9 welcomed the extensive research and careful deliberation that went into Easypower’s process of choosing a partner,” said Spider9 President and Chief Executive Officer, Glynne Townsend. “We look forward to a long and lasting relationship with one of Europe’s leading solar and storage pioneers and to the opportunity to make renewable energy cost-effective and reliable.”

Today’s announcement is the first of several projects that Spider9 and Easypower are collaborating on in astationary energy storage market that is forecasted to grow into a $20 billion industry by 2020. Through this partnership the two companies will be able to provide grid-tied, off-grid, and microgrid systems for residential, commercial and grid scale applications that incorporate both traditional solar and wind-based renewable energy generation.

About Spider9 Inc.

Spider9, Inc. is a Northville, MI-based Startup Company that uses their dynamic energy operating system to make renewable energy generation and storage more effective and affordable. Led by a team of former Fortune 500 executives, Spider9 was founded with the goal of decreasing the cost and increasing the viability of renewable energy. For more information on Spider9, please visit http://www.Spider9.com .

About Easypower S.A.

Easypower S.A.was founded in 2007 and is a founding member of the Hellenic Association of Photovoltaic Energy Producers (HAPEP). They are one of Europe’s leading companies specialized in the creation, investment and management of electrical power production units and boast some of the world’s highest-performing solar installations. A firm believer in the benefits of renewable energy generation integrated with energy storage, Easypower has pioneered the implementation and growth of advanced storage and renewable energy systems. For more information on Easypower S.A., please visit http://www.easypower.gr/.


Terumo CVS to Invest $4.9 Million in Ann Arbor Headquarters, Receives Ann Arbor SPARK and Scio Township Support

Terumo Cardiovascular Systems Corporation (Terumo CVS) has been awarded a 12-year property tax abatement by Scio Township for $4.9 million in investments for capital improvements at its Ann Arbor facility.

Ann Arbor SPARK provided assistance to Terumo CVS in identifying and applying for the tax incentives.

“Terumo CVS has been a part of the Ann Arbor region’s growing economy for several years; it’s exciting to support the next step in its evolution,” said Paul Krutko, Ann Arbor SPARK president and CEO.  “Working with our partners in Scio Township to create an incentives package that helps support Terumo CVS’ sustained growth is exactly the collaboration needed to make economic development efforts successful.”

Terumo manufactures products for cardiac and vascular surgery to hospitals worldwide. The incentives will help support improvements that will directly support the retention of the company’s current 600-person workforce.

“We are grateful to Scio Township for granting Terumo this important tax exemption that will enable us to invest additional resources and expand our business operations in Washtenaw County.  Terumo has been part of the fabric of this community for many years, because of the strong business support and exceedingly talented workforce that lives here,” said Mark Sutter President and chief executive officer, Terumo CVS.  “Terumo is also thankful for the leadership, guidance and support that Ann Arbor SPARK provided to us during the entire process. Our organizations have a long-standing relationship and we appreciate having this valuable resource available to us.”

In addition to assisting with this current incentives package awarded by Scio Township, Ann Arbor SPARK has worked closely with Terumo on previous incentives to support its growth in the region.  Ann Arbor SPARK has also provided the company with support for its talent and hiring needs.

Mark Sutter was recently featured in the Pure Michigan Business Attraction video: Why Ann Arbor? Watch it below:


Atterocor, Inc. Announces $16 Million Series A Venture Capital Financing

Atterocor, Inc., a company developing an innovative therapy for adrenal cancer, today announced a $16 million Series A venture capital financing. Frazier Healthcare and 5AM Ventures led the round and proceeds from the financing will support Atterocor’s accelerated development of its lead program.

“We are excited to launch Atterocor with this Series A funding, which will enable us to rapidly and efficiently advance our lead program to the clinic,” said Julia Owens, Ph.D., founder, president and chief executive officer of Atterocor. “Adrenal cancer is a rare disease for which there are very limited treatment options and a critical patient need. Now that we have secured financing for this program, we will continue to focus on achieving key corporate and clinical development milestones and look forward to providing updates around our future progress.”

Joining Dr. Owens as founders of the Company are Raili Kerppola, Ph.D., MBA, who serves as chief operating officer and Gary Hammer, M.D., Ph.D., who is the Millie Schembechler Professor of Adrenal Cancer, director of the endocrine oncology program and director of the center for organogenesis at the University of Michigan and will serve as a scientific advisor to the Company.

Adrenal cancer is often diagnosed in the late stages of disease when there is a very poor patient prognosis. This form of cancer is rare with approximately 600 patients diagnosed in the U.S. each year. Current treatment options are extremely limited and often ineffective and poorly tolerated in many patients.